Vertex’s Type 1 Diabetes Cell Therapy Gets A Boost – And Some Competition
Sernova One Step Ahead On Implantable Device
Vertex has invested heavily in advancing its stem-cell based candidates for type 1 diabetes, but Sernova has inched ahead in the race to bring a functional cure for the condition to patients.
